| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $914.2M | -44.8% |
| Cost of Revenue | $262.8M | -73.7% |
| Gross Profit | $651.5M | -0.9% |
| R&D Expense | $146.2M | +18.1% |
| SG&A Expense | $152.8M | +108.9% |
| Operating Income | $32.6M | -69.9% |
| Pre-tax Income | $51.7M | -53.6% |
| Income Tax | $29.6M | -8.6% |
| Net Income | $36.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $291.4M | -37.9% |
| Short-term Investments | $20.7M | — |
| Accounts Receivable | $40.0M | -14.6% |
| Inventory | $331K | -93.7% |
| Current Assets | $391.2M | -29.8% |
| Total Assets | $918.9M | -0.9% |
| Current Liabilities | $115.2M | +16.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $124.5M | -51.4% |
| Capital Expenditures | $24.6M | +314.6% |
| Investing Cash Flow | -$61.6M | -184.6% |
| Financing Cash Flow | -$253.6M | -173.9% |
| Free Cash Flow | $100.0M | -60.0% |
| -56.2% |
| EPS (Basic) | $0.27 | -83.5% |
| EPS (Diluted) | $0.19 | -69.4% |
| Long-term Debt |
| $0 |
| — |
| Total Liabilities | $302.1M | +94.0% |
| Stockholders' Equity | $616.9M | -16.0% |